After valsartan recall, study offers 'modest reassurance' on cancer risk
(Source: CNN.com - Health)
Source: CNN.com - Health - September 12, 2018 Category: Consumer Health News Source Type: news
Valsartan Tablets (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 10, 2018 Category: Drugs & Pharmacology Source Type: news
FDA warns blood pressure drugs investigation for cancer-causing chemical
The FDA is investigating a broader set of medications that may be repackaged valsartan after recalling the popular blood pressure drug over its discovery that it contains a carcinogen, the agency said today. (Source: the Mail online | Health)
Source: the Mail online | Health - August 31, 2018 Category: Consumer Health News Source Type: news
FDA investigation into heart drug valsartan may lead to more recalls
The US Food and Drug Administration said Thursday that it is conducting an extensive investigation into an entire class of drugs over potential cancer risk. (Source: CNN.com - Health)
Source: CNN.com - Health - August 30, 2018 Category: Consumer Health News Source Type: news
Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA ’s ongoing investigation into valsartan impurities and recalls and an update on FDA’s current findings
FDA update on the ongoing investigation into valsartan impurities, recalls and current findings. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 30, 2018 Category: American Health Source Type: news
Recall of heart drug valsartan continues to expand
The US Food and Drug Administration has again expanded the list of recalled medications that contain valsartan, used as a component in a set of drugs to treat heart failure and blood pressure. (Source: CNN.com - Health)
Source: CNN.com - Health - August 28, 2018 Category: Consumer Health News Source Type: news
Toxin At Heart Of Drug Recall Shows Holes in Medical Safety Net Toxin At Heart Of Drug Recall Shows Holes in Medical Safety Net
A toxin inadvertently produced in the manufacture of the widely prescribed medicine valsartan but not spotted for years raises questions about regulators ' ability to detect risks in a sprawling global drug supply chain increasingly reliant on factories in China.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 24, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling ALL LOTS within expiry of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. The impurity detected in the API is N-nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer ...
Source: Food and Drug Administration - August 22, 2018 Category: Food Science Source Type: news
UPDATED:ADDITIONAL LOTS ADDED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling ALL LOTS within expiry of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. The impurity detected in the API is N-nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer ...
Source: Food and Drug Administration - August 22, 2018 Category: Food Science Source Type: news
Health Canada expands recall of some heart, high blood pressure drugs
Health Canada has added eight more products to its recall of certain medications containing valsartan, a drug used to treat high blood pressure and heart failure, after probable carcinogens were found in some. (Source: CBC | Health)
Source: CBC | Health - August 20, 2018 Category: Consumer Health News Tags: News/Health Source Type: news
Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling 14 lots of Valsartan/Amlodipine/HCTZ tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. The impurity detected in the API is N-nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 18, 2018 Category: Food Science Source Type: news
More Drug Makers Tagged as Valsartan Recall Grows
More than 20 European countries, Canada, and the United States have recalled valsartan medications in recent weeks after NDMA was discovered in the drugs’ ingredients manufactured by Zhejiang Huahai Pharmaceuticals of Linhai, China. (Source: WebMD Health)
Source: WebMD Health - August 13, 2018 Category: Consumer Health News Source Type: news
Tainted Valsartan Recall Expands
as More Drug Makers Implicated (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 13, 2018 Category: General Medicine Source Type: news
India ’s Hetero pulls heart drug from U.S. amid cancer risk probes
A unit of India ’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug. (Source: Reuters: Health)
Source: Reuters: Health - August 11, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Tainted Valsartan Recall Expands as More Drug Makers Implicated Tainted Valsartan Recall Expands as More Drug Makers Implicated
News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news
